Hims weight loss review: complete 2026 guide
Honest Hims weight loss review covering GLP-1 pricing, program structure, medication options, and how Hims compares to other telehealth weight loss platforms.
Rating summary
Overall: 4.0 / 5
Pros:
- Publicly traded company (NYSE: HIMS) with established reputation
- Multiple medication tiers from oral weight loss pills to injectable GLP-1s
- All-inclusive pricing with no hidden fees
Cons:
- Multi-month commitments required for the best pricing
- Compounded medications are not FDA-approved
- No 1:1 video coaching included in the base plan
Hims started as a men’s health platform for hair loss and ED. Over the past two years, their weight loss program has become one of their fastest-growing lines. They now offer everything from oral weight loss medications to compounded semaglutide injections through an all-in-one subscription model.
But a big brand name doesn’t automatically mean the best value. We broke down what Hims actually offers, what it costs, and where it fits compared to other options.
What is Hims weight loss?
Hims (officially Hims & Hers Health, Inc.) is a publicly traded telehealth company that expanded into weight loss in 2023. The platform offers several medication tiers for weight management, ranging from prescription oral medications to compounded GLP-1 injections.
Unlike some competitors that focus exclusively on GLP-1 medications, Hims offers a tiered approach. You can start with less expensive oral medications and step up to injectables if needed. This gives patients who don’t want to jump straight to injections a more gradual entry point.
The company works with licensed physicians and compounding pharmacies across the US. Their GLP-1 medications are compounded versions of semaglutide, not the brand-name Wegovy or Ozempic. This is the same approach used by most telehealth weight loss platforms, including Medvi and Henry Meds.
How it works
Hims uses a structured onboarding process:
-
Online assessment: You answer questions about your health history, weight goals, and medication preferences. The questionnaire includes BMI screening. Most weight loss medications require a BMI of 27+ with a weight-related condition, or 30+ without one.
-
Provider review: A licensed provider reviews your information and may follow up with messages or a brief video consultation. Turnaround is typically 24-48 hours.
-
Medication selection: Based on your assessment and provider recommendation, you’re matched with a medication tier. Options range from oral medications (like metformin or bupropion/naltrexone) to compounded injectable semaglutide.
-
Subscription and shipping: Your medication ships monthly. The subscription includes ongoing provider access through the Hims app for dosage adjustments and questions.
The platform is designed for convenience. Everything happens through the app, including consultations, prescription management, and refill tracking.
One thing Hims does differently from most competitors: they offer a weight loss program that starts with non-GLP-1 medications. If your provider determines you’re a candidate for oral weight loss pills first, you can try that approach at $69-85/month before committing to injectables. This step-up model is uncommon in the telehealth weight loss space, where most platforms jump straight to semaglutide.
Pricing breakdown
Hims uses a tiered pricing model. What you pay depends on the medication and your commitment length.
Medication tiers and pricing
| Tier | What’s included | Monthly cost | Commitment |
|---|---|---|---|
| Oral weight loss | Prescription oral medication (e.g., metformin, bupropion/naltrexone) | $69-85/mo | 10-month plan, paid upfront |
| Compounded semaglutide | Injectable compounded semaglutide + supplies | $199/mo | 6-month plan, paid upfront |
| Brand-name GLP-1 | Wegovy, Ozempic, or Zepbound (if insurance covers it) | Varies | Insurance-dependent |
The $199/month compounded semaglutide price requires a 6-month commitment paid upfront ($1,194 total). Month-to-month pricing runs higher. This is a common strategy among telehealth platforms to lock in customers, and it means you should be reasonably confident you’ll stick with the program before committing.
What’s included
All tiers include:
- Licensed provider consultation and ongoing access
- Medication (one month supply per shipment)
- Free shipping
- Access to the Hims app with progress tracking
- Syringes and supplies for injectable medications
What’s not included
Hims doesn’t provide 1:1 video coaching sessions like some premium competitors (Calibrate, for example). Support is primarily text-based through the app. If you want a structured coaching program with regular video check-ins, you’ll need to look elsewhere or supplement with your own nutritionist.
Pricing comparison
| Provider | Compounded semaglutide | Commitment | Video consults |
|---|---|---|---|
| Hims | $199/mo (6-mo plan) | 6 months upfront | Limited |
| Medvi | $179 first mo / $299 ongoing | Month-to-month available | No (async only) |
| Henry Meds | $197-297/mo | Varies | Some |
| PURE Peptide Clinic | $197/mo | Month-to-month | Yes, every patient |
| Brand Wegovy (retail) | $1,349/mo | None | Varies |
Pros and cons
What works well:
Hims is a real company with real oversight. As a publicly traded company, they face SEC reporting requirements and regulatory scrutiny that smaller startups don’t. This doesn’t guarantee a perfect experience, but it means they have more to lose from cutting corners.
The tiered medication approach is genuinely useful. Not everyone needs injectable semaglutide. Some patients respond well to oral medications that cost a fraction of the price. Starting at $69/month for oral options and stepping up only if needed is a rational approach.
Their app is polished and easy to use. Prescription tracking, messaging, and refill management work smoothly. For people who prefer managing their healthcare through their phone, Hims does this better than most competitors.
Where it falls short:
The upfront commitment is the biggest drawback. Paying $1,194 upfront for six months of compounded semaglutide is a meaningful financial commitment, especially since you won’t know how you’ll respond to the medication for the first 4-8 weeks. If you experience intolerable side effects at week three, getting a refund for the remaining five months may be difficult.
The compounded semaglutide is not FDA-approved. This is true across all compounded GLP-1 providers, not just Hims. In the STEP 1 clinical trial, FDA-approved semaglutide 2.4mg produced an average weight loss of 14.9% over 68 weeks [1]. Compounded versions contain the same active ingredient but are manufactured under different quality controls.
Provider access is primarily text-based. You can message your provider through the app, and they typically respond within a day. But if you want real-time conversation about side effects or dosing concerns, the experience can feel impersonal.
Real user experiences
Hims has a large volume of reviews across multiple platforms, which gives a more reliable picture than smaller competitors.
Trustpilot reviews for Hims overall (across all product lines) trend positive, though weight-loss-specific reviews are mixed into the broader rating. Common praise includes easy signup and consistent delivery. Common complaints include auto-renewal charges and difficulty reaching customer support.
Reddit communities like r/semaglutide include Hims users who report standard GLP-1 results. Weight loss timelines generally align with what clinical data predicts: 5-10% body weight in the first 3-4 months for most patients. The compounded medication appears to work as expected for the majority.
The most common negative feedback across platforms relates to billing, not medication. Auto-renewal, cancellation friction, and unexpected charges come up repeatedly. This is a pattern across most subscription-based telehealth companies, not unique to Hims.
One specific complaint worth highlighting: some users report that cancelling a prepaid plan mid-term doesn’t always result in a refund for unused months. If you prepay for 6 months and decide to stop at month 3, getting your remaining balance back may require persistence. Read the refund terms carefully before committing to any prepaid plan.
The app itself gets consistently positive reviews. Users appreciate the clean interface, easy prescription tracking, and quick notification when shipments are on their way. For people who manage multiple Hims products (hair loss, ED, weight loss), the unified app is a genuine convenience.
How PURE compares
At PURE Peptide Clinic, we do a few things differently:
No long-term commitments. Our $197/month pricing is month-to-month. You don’t need to pay $1,194 upfront to get our best price. Cancel anytime without negotiating.
Video consultations for every patient. Weight loss medications affect your heart rate, blood sugar, and GI system. A text conversation isn’t enough for some patients, especially during the titration phase. We include video check-ins with your prescribing provider.
Same medications, transparent pricing. We offer compounded semaglutide and tirzepatide at a flat $197/month. No tiers, no introductory pricing, no bait-and-switch.
Hims has advantages in brand recognition and the tiered medication approach. If you want to start with oral weight loss medication before trying injectables, Hims makes that easy. If you already know you want compounded GLP-1 injections with direct physician oversight, PURE offers more value per dollar.
Verdict
Hims is a solid option for people who want a well-known brand with a structured approach to weight loss. The tiered medication system is genuinely useful for patients unsure whether they need injectable GLP-1s. The app experience is among the best in telehealth.
The main drawbacks are the upfront commitment for the best pricing and limited live provider interaction. If you’re comfortable with text-based care and willing to pay upfront, Hims delivers reliable service.
For patients who want month-to-month flexibility and video consultations with their provider, check out PURE Peptide Clinic.
If you’re specifically looking at competitors in this space, we also reviewed Medvi and Calibrate, which each take a different approach to telehealth weight loss.
FAQ
Does Hims prescribe Ozempic or Wegovy?▼
Hims can prescribe brand-name GLP-1 medications like Wegovy and Ozempic if your insurance covers them. However, their main offering is compounded semaglutide, which is more affordable but not FDA-approved. The brand-name option requires insurance verification.
How much weight can you lose on Hims?▼
Weight loss depends on the medication, dosage, and your adherence to diet and exercise. In clinical trials, semaglutide 2.4mg produced average weight loss of 14.9% over 68 weeks [1]. Compounded semaglutide should produce similar results since it contains the same active ingredient, though individual outcomes vary.
Is Hims weight loss only for men?▼
No. Despite the brand name, Hims & Hers serves both men and women. Their weight loss program is available to adults of any gender who meet the medical criteria. The “Hers” side of the platform offers identical weight loss services marketed toward women.
Can I cancel my Hims weight loss subscription?▼
Yes, but the terms depend on your plan. Month-to-month plans can be cancelled anytime. Prepaid multi-month plans may have different refund policies. Check the terms before committing, and be aware that several user reviews mention friction during the cancellation process.
How does Hims compare to Medvi?▼
Hims offers a broader range of medications (oral and injectable) while Medvi focuses on compounded GLP-1 injectables. Hims has a lower compounded semaglutide price ($199 vs $299/month ongoing), but requires a 6-month prepay. Medvi’s $179 first month is cheaper, but the ongoing cost is higher. Both use async provider communication as the default.
References
-
Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. PubMed
-
Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216. PubMed
-
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults. Nat Med. 2025. PubMed
-
FDA. Compounded drugs containing semaglutide or tirzepatide: Safety information. FDA.gov
-
Hims & Hers Health, Inc. Weight loss program pricing. Hims.com
Get guides like this delivered weekly.
Evidence-based peptide research, protocol breakdowns, and provider reviews.
Get the Weekly Brief